• Title of article

    Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

  • Author/Authors

    Florian Klein، نويسنده , , Ron Diskin، نويسنده , , Johannes F. Scheid، نويسنده , , Christian Gaebler، نويسنده , , Hugo Mouquet، نويسنده , , Ivelin S. Georgiev، نويسنده , , Marie Pancera، نويسنده , , Tongqing Zhou and Peter D. Kwong، نويسنده , , Reha-Baris Incesu، نويسنده , , Brooks Zhongzheng Fu، نويسنده , , Priyanthi N.P. Gnanapragasam، نويسنده , , Thiago Y. Oliveira، نويسنده , , Michael S. Seaman، نويسنده , , Peter D. Kwong، نويسنده , , Pamela J. Bjorkman، نويسنده , , Michel C. Nussenzweig، نويسنده ,

  • Issue Information
    هفته نامه با شماره پیاپی سال 2013
  • Pages
    13
  • From page
    126
  • To page
    138
  • Abstract
    Broadly neutralizing antibodies (bNAbs) to HIV-1 can prevent infection and are therefore of great importance for HIV-1 vaccine design. Notably, bNAbs are highly somatically mutated and generated by a fraction of HIV-1-infected individuals several years after infection. Antibodies typically accumulate mutations in the complementarity determining region (CDR) loops, which usually contact the antigen. The CDR loops are scaffolded by canonical framework regions (FWRs) that are both resistant to and less tolerant of mutations. Here, we report that in contrast to most antibodies, including those with limited HIV-1 neutralizing activity, most bNAbs require somatic mutations in their FWRs. Structural and functional analyses reveal that somatic mutations in FWR residues enhance breadth and potency by providing increased flexibility and/or direct antigen contact. Thus, in bNAbs, FWRs play an essential role beyond scaffolding the CDR loops and their unusual contribution to potency and breadth should be considered in HIV-1 vaccine design.
  • Journal title
    CELL
  • Serial Year
    2013
  • Journal title
    CELL
  • Record number

    1021641